Locked price vs escalating price
MedVi vs TMates: Which Price Survives Titration? (2026)
MedVi costs $3,468 a year against $2,388 for TMates. Full 2026 comparison of price, medication class and included support.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.2 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
MedVi versus TMates is a common shortlist, and it is a more interesting one than the two homepages suggest.
GLP-1 dosing escalates over the first few months, and providers differ on whether the invoice escalates with it. TMates holds one rate at every dose; MedVi's price moves from $179 to $299.
The sections that follow price both programs across a full course of treatment rather than a first month, then set out which patient each one is actually built for. No number here is inferred; if a provider does not publish it, the table says so.
The short answer
- Lowest 12-month cost
- TMates — $2,388 against $2,592 at MedVi, on each provider's own best published pricing.
- Most predictable bill
- TMates — Flat rate at every dose, so titration does not change what you are charged.
- Quickest to start
- MedVi — Simple online process, no clinic visits, then fast, free shipping.
- Widest medication choice
- MedVi — compounded semaglutide.
MedVi vs TMates at a glance
The table is built from each provider's published pricing and program detail; anything they decline to state is marked as such.
| MedVi | TMates | |
|---|---|---|
| Advertised price | $179 promotional first month | $199/mo at every dose, no step-up fees |
| Rate after promotions | $299/mo | $199/mo |
| Pricing structure | Promotional first month, then standard rate | Flat rate at every dose |
| Medication | Compounded semaglutide | Compounded semaglutide |
| How fast you start | Simple online process, no clinic visits | Virtual check-in appointments |
| State coverage | Not published | All 50 states |
| Payment options | Card only, no financing published | Card only, no financing published |
| Membership fee | None | None |
| Patient reviews | 12,896 | 21,970 |
| eRxDoctor score | 9.2/10 | 7.0/10 |
The real cost: six months and twelve
GLP-1 treatment is not a one-month purchase, and neither of these prices it like one. What matters is the total at the point most people are still in treatment, so both programs are extended to six and twelve months below.
| MedVi | TMates | |
|---|---|---|
| First month | $179 | $199 |
| Months 2 onward | $299/mo | $199/mo |
| 6-month total | $1,674 | $1,194 |
| 12-month total | $3,468 | $2,388 |
| Best published plan | 3-month plan at $649 — $2,592/yr | No multi-month discount published |
Over a year that is a $204 difference, in TMates's favor. Whether it is the right call depends on whether MedVi gives you $17 a month of something you will use.
Price escalation to plan for: MedVi moves from $179 to $299, a 67% increase. Set a calendar reminder for the month it changes.
What happens to the price as your dose goes up
Semaglutide and tirzepatide are titrated upward over the first months of treatment. Some providers price per milligram in all but name, so the invoice climbs alongside the dose; others hold one rate the whole way.
TMates is in the second group: one flat $199 that survives every titration step, with doctors rather than a message queue behind it. MedVi is in the first — the price roughly doubles to $299 once the promotional month ends — which means the number you compared at signup is not the number you will be paying at month four.
Before signing up anywhere, get the top-dose price. A program that will not quote it is telling you something.
How MedVi works
The pitch is a genuinely low promotional entry point with 24/7 clinical support behind it. MedVi provides compounded semaglutide starting at $179/month with a simple online intake, no clinic visits, and 24/7 certified medical support for weight loss.
Getting started means simple online process, no clinic visits, after which fast, free shipping. Pricing runs on a promotional first month, then standard rate basis, published upfront.
24/7 support from certified medical professionals. The formulary covers compounded semaglutide.
MedVi pros
- 24/7 support from certified medical professionals
- Simple online process with no clinic visits required
- Low promotional first month at $179 including fast, free shipping
- Clinically dosed compounded semaglutide
MedVi cons
- No published outcome or weight loss guarantee
- Compounded medication only, no branded Ozempic or Wegovy
- Semaglutide only, no tirzepatide option
Where it gives ground to TMates: the price roughly doubles to $299 once the promotional month ends.
A closer look at TMates
$199/month, every dose, no step-up fees In this pairing, its distinguishing feature is one flat $199 that survives every titration step, with doctors rather than a message queue behind it.
The process is virtual check-in appointments, then medication formulated in U.S. facilities. On money, expect flat rate at every dose — published upfront.
Support: 24/7 access to U.S.-based doctors, not just messaging. The medications on offer are compounded semaglutide.
TMates pros
- Medications formulated in U.S.-based facilities
- Licensed coverage in all 50 states
- 24/7 access to U.S.-based doctors, not just messaging support
- Flat $199/month at every dose, no step-up fees as dosage escalates
TMates cons
- No branded Ozempic, Wegovy, or Zepbound
- $199/month is higher than the cheapest compounded options
- Compounded semaglutide only, limited public detail on tirzepatide availability
Read next to MedVi, the weak point: semaglutide only, and $199 is well above the cheapest compounded options.
MedVi or TMates: matching the program to the patient
Choose MedVi if:
- delivery works the way you want it to: fast, free shipping
- you want to start on their timeline: simple online process, no clinic visits
- the level of clinical contact suits you: 24/7 support from certified medical professionals
- the feature you would actually use: a genuinely low promotional entry point with 24/7 clinical support behind it
Choose TMates if:
- you are in a state where GLP-1 telehealth coverage is patchy
- the twelve-month total is what you are optimizing ($2,388 against $3,468)
- the monthly rate is the constraint — $199/mo against $299/mo
- you want the price you sign up at to survive titration
The trade-offs, stated plainly
On price. $199/mo against $299/mo. MedVi is asking you to pay for a genuinely low promotional entry point with 24/7 clinical support behind it; decide whether that is a line item you will use.
On commitment. MedVi rewards a longer commitment (3-month plan at $649), which lowers the effective rate but ties up money before you know how you respond to the medication. Neither publishes financing options, so plan for the full amount each month.
On access. MedVi advertises simple online process, no clinic visits and fast, free shipping; TMates advertises virtual check-in appointments and medication formulated in U.S. facilities. Coverage differs too — not published against all 50 states — which decides the question before price does if you are in a restricted state.
On predictability. Promotional first month, then standard rate versus flat rate at every dose. Whichever you pick, get the maintenance-dose price in writing at intake.
The clinical evidence, separated from the marketing
Neither MedVi nor TMates manufactures the molecule it prescribes, and the clinical evidence behind GLP-1 treatment belongs to the drug rather than to any platform selling access to it.
Compounding is lawful within a specific statutory framework, and the conditions attached to it have changed as GLP-1 shortages have resolved, per FDA.
Compounded medication occupies a different regulatory category entirely: no approval application, and no FDA verification of what is in the vial, per FDA.
Take the clinical questions to the prescribing clinician at whichever platform you choose; take the pricing questions to their support team before you pay.
MedVi vs TMates: common questions
What happens when MedVi's promotional price ends?
The rate moves to $299/mo, a 67% increase on the advertised entry price. Budget from that number rather than the headline, because it is the one you will pay for eleven of your first twelve months.
Is TMates cheaper than MedVi?
Yes, on the ongoing rate. TMates runs $199/mo once promotional pricing ends, against $299/mo at MedVi — a difference of 50%. Compare the first-month offers separately, because both providers discount entry differently from the rate you will actually be paying by month three.
Which costs less over a year, MedVi or TMates?
TMates, at roughly $2,388 for twelve months against $2,592 at MedVi, using each provider's own best published pricing. Those totals cover medication and program fees as published; they exclude anything a provider bills separately, and they assume you stay on the same plan for the full year.
Which has more patient reviews, MedVi or TMates?
TMates, with 21,970 against 12,896. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Do MedVi or TMates take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
Do MedVi and TMates prescribe the same medication?
Both dispense compounded GLP-1 preparations. MedVi lists compounded semaglutide and TMates lists compounded semaglutide, so the molecules overlap even where the formulary does not match exactly.
The verdict
On the numbers, TMates wins the year: $2,388 against $2,592. That is the default answer, and it is the right one for anyone who mainly needs a reliable prescription and a shipment that arrives.
MedVi earns the difference in one situation: when a genuinely low promotional entry point with 24/7 clinical support behind it is something you will genuinely use. If you cannot say that out loud, take the cheaper program.
The failure mode here is not picking the wrong platform; it is stopping treatment because the bill moved. Choose the one whose bill you can predict.
Keep comparing
- MedVi vs JoinFridaysTirzepatide access
- Wellmedr vs MedViBudget vs premium
- Wellorithm vs TMatesPublished price vs quote-only
- Embody vs TMatesBudget vs premium
- TMates vs He & She MDLocked price vs escalating price
- He & She MD vs MaximusLocked price vs escalating price
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by MedVi or TMates, and does not sell treatment. Read our ranking methodology.